Astex announces new drug discovery collaboration with University of Newcastle upon Tyne and Cancer Research Technology Limited

Astex announces new drug discovery collaboration with University of Newcastle upon Tyne and Cancer Research Technology Limited

Studies of Nipent® in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease (GVHD) Presented at American Society of Hematology Annual Meeting

Studies of Nipent® in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease (GVHD) Presented at American Society of Hematology Annual Meeting